Deborah D. Ascheim, MD is chief medical officer of Capricor, Inc., a biotechnology company focused on the discovery, development, and commercialization of first-in-class therapeutics. She is also professor of medicine in the Department of Medicine and Heart Institute at Cedars Sinai Medical Center in Los Angeles, CA. Dr. Ascheim was elected to the PHR board of directors in 2008, and served as board chair from 2013 to 2016. She has been volunteering with the organization and providing medical evaluations for the PHR Asylum Network since 2005.
Dr. Ascheim holds a BA from Wellesley College, where she graduated cum laude. She received her MD from New York University Medical School, and completed her internship and residency in internal medicine, as well as her fellowship in cardiovascular diseases, at the New York-Presbyterian/Weill Cornell Medical Center. She completed a post-graduate fellowship in heart failure at Columbia University College of Physicians and Surgeons, and remained on as a member of the faculty and as an attending cardiologist in the Heart Failure Center at the College of Physicians and Surgeons and the Mailman School of Public Health from 1995 to 2008. In 2008, Dr. Ascheim joined the faculty of the Icahn School of Medicine at Mount Sinai, where she was most recently professor of medicine (cardiology) and health policy in the Departments of Medicine/Cardiovascular Institute and of Health Evidence and Policy. She also served as clinical director of research and director of the Clinical Research Unit at the International Center for Health Outcomes and Innovation Research (InCHOIR) at Mount Sinai. Her work has been published in journals such as the New England Journal of Medicine, Circulation, Journal of the American College of Cardiology, Journal of Cardiac Failure, the Annals of Thoracic Surgery, and the Journal of Heart Lung Transplant.